Search

Your search keyword '"Ferreira, Vanessa M."' showing total 64 results

Search Constraints

Start Over You searched for: Author "Ferreira, Vanessa M." Remove constraint Author: "Ferreira, Vanessa M." Publisher elsevier b.v. Remove constraint Publisher: elsevier b.v.
64 results on '"Ferreira, Vanessa M."'

Search Results

1. Diagnostic utility of electrocardiogram for screening of cardiac injury on cardiac magnetic resonance in post-hospitalised COVID-19 patients: a prospective multicenter study

2. Cardiovascular Magnetic Resonance Before Invasive Coronary Angiography in Suspected Non–ST-Segment Elevation Myocardial Infarction.

7. Worldwide variation in cardiovascular magnetic resonance practice models.

8. Incident Clinical and Mortality Associations of Myocardial Native T1 in the UK Biobank.

9. Cardiovascular magnetic resonance for evaluation of cardiac involvement in COVID-19: recommendations by the Society for Cardiovascular Magnetic Resonance.

10. Acute Response in the Noninfarcted Myocardium Predicts Long-Term Major Adverse Cardiac Events After STEMI.

11. Cardiovascular Magnetic Resonance for Patients With COVID-19.

12. Coronary Microvascular Dysfunction Assessed by Pressure Wire and CMR After STEMI Predicts Long-Term Outcomes.

14. Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: protocol design of COVID-HEART—a UK, multicentre, observational study.

15. Cardiovascular magnetic resonance in women with cardiovascular disease: position statement from the Society for Cardiovascular Magnetic Resonance (SCMR).

16. Left atrial 4D flow cardiovascular magnetic resonance: a reproducibility study in sinus rhythm and atrial fibrillation.

17. Rationale and design of the Medical Research Council's Precision Medicine with Zibotentan in Microvascular Angina (PRIZE) trial.

18. Cardiovascular disease in women: insights from magnetic resonance imaging.

19. Myocardial Tissue Characterization and Fibrosis by Imaging.

20. Hyper-acute cardiovascular magnetic resonance T1 mapping predicts infarct characteristics in patients with ST elevation myocardial infarction.

23. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations.

25. Editorial Expression of Concern: Splenic T1-mapping: a novel quantitative method for assessing adenosine stress adequacy for cardiovascular magnetic resonance.

26. Adenosine stress CMR T1-mapping detects early microvascular dysfunction in patients with type 2 diabetes mellitus without obstructive coronary artery disease.

27. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI).

28. Measurement of myocardial native T1 in cardiovascular diseases and norm in 1291 subjects.

29. The global cardiovascular magnetic resonance registry (GCMR) of the society for cardiovascular magnetic resonance (SCMR): its goals, rationale, data infrastructure, and current developments.

30. Splenic T1-mapping: a novel quantitative method for assessing adenosine stress adequacy for cardiovascular magnetic resonance.

32. Pheochromocytoma Is Characterized by Catecholamine-Mediated Myocarditis, Focal and Diffuse Myocardial Fibrosis, and Myocardial Dysfunction.

33. Adenosine Stress and Rest T1 Mapping Can Differentiate Between Ischemic, Infarcted, Remote, and Normal Myocardium Without the Need for Gadolinium Contrast Agents.

34. T1 Mapping of the Remote Myocardium: When Normal Is Not Normal.

35. Systolic ShMOLLI myocardial T1-mapping for improved robustness to partial-volume effects and applications in tachyarrhythmias.

36. Adenosine stress native T1 mapping in severe aortic stenosis: evidence for a role of the intravascular compartment on myocardial T1 values.

37. Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents.

38. Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis - a clinical study using myocardial T1-mapping and extracellular volume quantification.

39. T1 Mapping for the Diagnosis of Acute Myocarditis Using CMR: Comparison to T2-Weighted and Late Gadolinium Enhanced Imaging.

41. Noncontrast T1 Mapping for the Diagnosis of Cardiac Amyloidosis.

42. Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI.

43. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance.

44. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1- mapping at 1.5 and 3 T within a 9 heartbeatbreathhold.

45. Gaussian modelling for operator-independent and threshold-free volumetric segmentation of phase sensitive inversion recovery late gadolinium enhanced images.

46. Quantification of acute myocardial injury by ShMOLLI T1-Mapping, T2-weighted and late gadolinium imaging in patients presenting with chest pain, positive troponins and non-obstructive coronary arteries.

47. Quantification of acute myocardial injury in STEMI patients post revascularization at 3Tesla. Comparison of T1-mapping, late gadolinium and edema imaging.

49. The quantitative assessment of microvascular obstruction size using first-pass perfusion cardiac MR.

50. Cardiovascular magnetic resonance stress and rest T1-mapping using regadenoson for detection of ischemic heart disease compared to healthy controls.

Catalog

Books, media, physical & digital resources